These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25490416)
1. Cardioprotection by ranolazine in perfused rat heart. Ghelardoni S; Chiellini G; Frascarelli S; Zucchi R J Cardiovasc Pharmacol; 2014 Dec; 64(6):507-13. PubMed ID: 25490416 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion. Dehina L; Descotes J; Chevalier P; Bui-Xuan B; Romestaing C; Dizerens N; Mamou Z; Timour Q Fundam Clin Pharmacol; 2014 Jun; 28(3):257-67. PubMed ID: 23607936 [TBL] [Abstract][Full Text] [Related]
3. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401 [TBL] [Abstract][Full Text] [Related]
4. Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application. Hwang H; Arcidi JM; Hale SL; Simkhovich BZ; Belardinelli L; Dhalla AK; Shryock JC; Kloner RA J Cardiovasc Pharmacol Ther; 2009 Jun; 14(2):125-33. PubMed ID: 19329672 [TBL] [Abstract][Full Text] [Related]
5. [Sarcoplasmic reticular calcium release and myocardial protection--effect of ryanodine on myocardial ischemia and reperfusion-induced injury]. Yamamoto H; Yamamoto F; Ichikawa H; Ohashi T; Yoshida S; Komai H; Takahashi A; Fujita T Nihon Kyobu Geka Gakkai Zasshi; 1994 Mar; 42(3):332-9. PubMed ID: 8176288 [TBL] [Abstract][Full Text] [Related]
6. Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart. Zucchi R; Yu G; Ghelardoni S; Ronca F; Ronca-Testoni S Br J Pharmacol; 2000 Sep; 131(2):342-8. PubMed ID: 10991929 [TBL] [Abstract][Full Text] [Related]
7. Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury. Khalaf A; Babiker F J Physiol Biochem; 2016 Sep; 72(3):495-508. PubMed ID: 27325083 [TBL] [Abstract][Full Text] [Related]
8. [Myocardial protection and the sarcoplasmic reticulum--the effect of ryanodine treatment prior to cardioplegic arrest on post-ischemic functional recovery]. Yamamoto H; Yamamoto F; Ichikawa H; Ohashi T; Goh K; Fujita T Nihon Kyobu Geka Gakkai Zasshi; 1994 Jun; 42(6):845-51. PubMed ID: 8057015 [TBL] [Abstract][Full Text] [Related]
9. Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. Dhalla AK; Wang WQ; Dow J; Shryock JC; Belardinelli L; Bhandari A; Kloner RA Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1923-9. PubMed ID: 19767532 [TBL] [Abstract][Full Text] [Related]
10. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. Hale SL; Kloner RA J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471 [TBL] [Abstract][Full Text] [Related]
11. Sulfhydryl redox state affects susceptibility to ischemia and sarcoplasmic reticulum Ca2+ release in rat heart. Implications for ischemic preconditioning. Zucchi R; Yu G; Galbani P; Mariani M; Ronca G; Ronca-Testoni S Circ Res; 1998 Nov; 83(9):908-15. PubMed ID: 9797339 [TBL] [Abstract][Full Text] [Related]
12. Protection of ischemic rat heart by dantrolene, an antagonist of the sarcoplasmic reticulum calcium release channel. Yu G; Zucchi R; Ronca-Testoni S; Ronca G Basic Res Cardiol; 2000 Apr; 95(2):137-43. PubMed ID: 10826506 [TBL] [Abstract][Full Text] [Related]
13. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. Fraser H; Belardinelli L; Wang L; Light PE; McVeigh JJ; Clanachan AS J Mol Cell Cardiol; 2006 Dec; 41(6):1031-8. PubMed ID: 17027025 [TBL] [Abstract][Full Text] [Related]
14. Effect of beta-adrenoceptor blockers on sarcoplasmic reticular function and gene expression in the ischemic-reperfused heart. Temsah RM; Dyck C; Netticadan T; Chapman D; Elimban V; Dhalla NS J Pharmacol Exp Ther; 2000 Apr; 293(1):15-23. PubMed ID: 10734148 [TBL] [Abstract][Full Text] [Related]
16. Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel. Hale SL; Leeka JA; Kloner RA J Pharmacol Exp Ther; 2006 Jul; 318(1):418-23. PubMed ID: 16617168 [TBL] [Abstract][Full Text] [Related]
17. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation. Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620 [TBL] [Abstract][Full Text] [Related]
18. Cardioprotection by ouabain and digoxin in perfused rat hearts. D'Urso G; Frascarelli S; Zucchi R; Biver T; Montali U J Cardiovasc Pharmacol; 2008 Oct; 52(4):333-7. PubMed ID: 18791463 [TBL] [Abstract][Full Text] [Related]
19. Preconditioning with Porphyromonas gingivalis lipopolysaccharide may confer cardioprotection and improve recovery of the electrically induced intracellular calcium transient during ischemia and reperfusion. Fan MH; Wong KL; Wu S; Leung WK; Yam WC; Wong TM J Periodontal Res; 2010 Feb; 45(1):100-8. PubMed ID: 19602110 [TBL] [Abstract][Full Text] [Related]
20. First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model. Kloner RA; Dow JS; Bhandari A J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):192-6. PubMed ID: 21193683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]